Clinical and morphological prognostic factors in patients with malignant pleura mesothelioma (MPM) Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Spread and histology of malignant tracheal tumor – as independent prognostic factors Source: Eur Respir J 2005; 26: Suppl. 49, 174s Year: 2005
Clinicopathologic features, histologic and immunohistochemical characteristics, and clinical outcome of patients with cardiac myofibroblastic tumors Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009
An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016
Clinical prognostic indicators of high-grade pre-invasive bronchial lesions Source: Eur Respir J 2004; 24: 24-29 Year: 2004
Clinicopathological prognostic factors in operated for lung cancer and brain metastasis patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines Year: 2009
Prognostic impact of radiological findings in unclassifiable interstitial lung diseases Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019
Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006
Clinicopathologic characteristics of primary bronchial cancer metastasizing to the brain Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
Bronchioalveolar lung carcinoma: its clinical, radiological and pathological features Source: Eur Respir J 2006; 28: Suppl. 50, 90s Year: 2006
Muscular metastasis from primary lung cancer: clinical and radiological features, about three cases Source: Eur Respir J 2006; 28: Suppl. 50, 76s Year: 2006
Evaluate of radiological, bronchoscopical and histopathological features of patients with primary lung cancer Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Prognostic impact of histology and treatment modalities in malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004
Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007
Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003
Prognostic value of metabolic imaging in non small cell lung cancers with neoplasic pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour Source: Eur Respir J, 59 (1) 2101058; 10.1183/13993003.01058-2021 Year: 2022